Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Limelight Networks, Chemed, Cigna, CURO Group and Huron Consulting Group

Read MoreHide Full Article

For Immediate Release

Chicago, IL – April 24, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Limelight Networks Inc. (LLNW, Chemed Corp. (CHE - Free Report) , Cigna Corp. (CI - Free Report) , CURO Group Holdings Corp. and Huron Consulting Group Inc. (HURN - Free Report) .

Here are highlights from Thursday’s Analyst Blog:

5 Top Growth Stocks to Buy Ahead of Q1 Earnings Reports

The first-quarter 2020 earnings season has been set in motion. However, corporate earnings are expected to suffer significantly on account of the coronavirus outbreak that spread like wildfire across the United States and all over the world in the second half of the first quarter.

Global economic activities almost came to a standstill in March as either partial or full lockdowns were imposed. In the absence of any vaccine or line of treatment, enforcing of social distancing was the only option to curb the spread of the deadly virus.

Nevertheless, growth investors are primarily focused on stocks with aggressive earnings or revenue improvement, which should propel their stock price higher in the future. Here are five growth stocks with a favorable Zacks Rank that are set to beat first-quarter earnings estimates this month.

Disappointing Q1 Earnings Results So Far

As of Apr 22, 83 S&P 500 members reported first-quarter 2020 earnings results. Total earnings of these companies are down 23.6% from the same period last year on 2.3% higher revenues. Of the total, 68.7% surpassed EPS estimates and 66.3% outpaced revenue estimates.

Overall, first-quarter  earnings for the S&P 500 Index were projected to be down 14.2% year over year on 1.2% higher revenues. This is in sharp contrast to 4% earnings growth expected in early January. (Read More: Making Sense of the Earnings Picture During the Coronavirus)

5 Growth Stocks Set to Beat Earnings Estimates

We have narrowed down our search to five growth stocks with a positive Earnings ESP that are slated to release earnings reports this month. Each of our picks carries either a Zacks Rank #1 (Strong Buy) or 2 (Buy) and Growth Score of A.  You can see the complete list of today’s Zacks #1 Rank tocks here.

Our research shows that for stocks with the combination of a Zacks Rank #3 or better and a positive Earnings ESP, the chance of an earnings beat is as high as 70%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Limelight Networks Inc. is a content delivery partner enabling the next wave of Internet business and entertainment in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The Zacks Rank #2 company has an Earnings ESP of +100%.

Limelight Networks has an expected earnings growth rate of 350% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 25% over the last 60 days. The company is set to release earnings results on Apr 23, after the closing bell.

Chemed Corp. provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The Zacks Rank #2 company has an Earnings ESP of +0.42%.

Chemed has an expected earnings growth rate of 18.9% for the current year. It has a trailing four-quarter positive earnings surprise of 1.5%, on average. The company is set to release earnings results on Apr 28, after the closing bell.

Cigna Corp. is a health service organization, provides insurance and related products and services. It operates through Health Services, Integrated Medical, International Markets, and Group Disability and Other segments. The Zacks Rank #2 company has an Earnings ESP of +1.47%.

Cigna has an expected earnings growth rate of 7.5% for the current year. It has a trailing four-quarter positive earnings surprise of 6.6%, on average. The company is set to release earnings results on Apr 30, before the opening bell.

CURO Group Holdings Corp. is a diversified consumer finance company providing consumer finance to a range of underbanked consumers in the United States, Canada and the United Kingdom. The Zacks Rank #1 company has an Earnings ESP of +1.47%.

CURO Group has an expected earnings growth rate of 12% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 6.4% over the last 60 days. It has a trailing four-quarter positive earnings surprise of 16.4%, on average. The company is set to release earnings results on Apr 30, after the closing bell.

Huron Consulting Group Inc. is a professional services firm, provides advisory, technology, and analytic solutions in the United States and internationally. The Zacks Rank #2 company has an Earnings ESP of +3.20%.

Huron Consulting Group has an expected earnings growth rate of 2.2% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.4% over the last 60 days. It has a trailing four-quarter positive earnings surprise of 22.7%, on average. The company is set to release earnings results on Apr 30, after the closing bell.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                   

http://www.zacks.com                                                 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cigna Group (CI) - free report >>

Huron Consulting Group Inc. (HURN) - free report >>

Chemed Corporation (CHE) - free report >>

Published in